Dividend investing remains one of the most reliable strategies for building long-term wealth, combining income generation with the compounding power of reinvested payouts over time.
The stocks listed below span healthcare, consumer defensives, utilities, real estate, and financial services. Each has been selected based on dividend consistency, sector durability, and long-term income potential.
Coca-Cola (KO)
Sector: Consumer Defensive
Exchange: NYSE
Coca-Cola is one of the most widely held dividend stocks in the world. The company operates in over 200 countries, giving it a revenue base that few consumer goods businesses can match.
Annual Dividend: $2.04 per share
Dividend Yield: 2.65%
Coca-Cola has one of the most durable brand moats in consumer goods. Consistent revenue growth, strong pricing power, and a global distribution network support reliable dividend payments over decades.
Johnson & Johnson (JNJ)
Sector: Healthcare
Exchange: NYSE
Johnson & Johnson is a global pharmaceutical and medical technology company. Its diversified business model spans consumer health, pharmaceuticals, and medical devices.
Annual Dividend: $5.20 per share
Dividend Yield: 2.16%
JNJ has raised its dividend for over 60 consecutive years. The combination of a low debt load, strong margins, and healthcare sector resilience makes it a cornerstone holding for income-focused portfolios.
Realty Income (O)
Sector: Real Estate
Exchange: NYSE
Realty Income, known as “The Monthly Dividend Company,” is a REIT that pays dividends monthly rather than quarterly. It is a constituent of the S&P 500 and MSCI World indexes.
Annual Dividend: $3.50 per share
Dividend Yield: 5.38%
Monthly dividend payments and a 5.38% yield make Realty Income one of the most income-friendly options on this list. Investors should note the REIT’s higher leverage profile and focus on the long-term revenue growth trajectory when assessing its durability.
PepsiCo (PEP)
Sector: Consumer Defensive
Exchange: NASDAQ
PepsiCo is a global food and beverage company with a portfolio that spans carbonated drinks, sports nutrition, and snacks. Its product diversity sets it apart from single-category peers.
Annual Dividend: $5.62 per share
Dividend Yield: 3.53%
PepsiCo has increased its dividend for over 50 consecutive years. Its dual exposure to beverages and snacks provides broader revenue diversification than pure-play beverage peers, supporting dividend stability through varying economic conditions.
Abbott Laboratories (ABT)
Sector: Healthcare
Exchange: NYSE
Abbott Laboratories develops and manufactures medical devices, diagnostics, nutritional products, and established pharmaceuticals. It operates across multiple healthcare categories rather than relying on a single revenue stream.
Annual Dividend: $2.40 per share
Dividend Yield: 2.19%
Abbott has raised its dividend for over 50 consecutive years and offers a meaningful discount to estimated fair value. High switching costs in medical devices and a broad patent portfolio support durable earnings and dividend growth.
AbbVie (ABBV)
Sector: Healthcare
Exchange: NYSE
AbbVie is a global biopharmaceutical company specialising in immunology, oncology, aesthetics, and neuroscience. It holds a market capitalisation of $409.69 billion.
Annual Dividend: $6.65 per share
Dividend Yield: 2.89%
AbbVie has grown its dividend significantly since its 2013 spin-off from Abbott. The transition from Humira to next-generation drugs Skyrizi and Rinvoq is progressing, while the Botox and Juvederm aesthetics franchise provides a durable revenue stream independent of pharmaceutical patent cycles.
NextEra Energy (NEE)
Sector: Utilities
Exchange: NYSE
NextEra Energy is the largest regulated electric utility in the United States by market capitalisation and is recognised as a global leader in wind and solar energy generation.
Annual Dividend: $2.32 per share
Dividend Yield: 2.55%
NextEra has increased its dividend for over 25 consecutive years and has guided for continued dividend growth through 2026. Its renewable energy leadership positions it well for long-term infrastructure investment themes tied to AI data centre power demand and electrification trends.
Merck (MRK)
Sector: Healthcare
Exchange: NYSE
Merck is a global pharmaceutical company whose primary revenue drivers include KEYTRUDA, which generated $25.0 billion in sales in 2023, and GARDASIL, which contributed $8.9 billion. It is rated Robust for capital management.
Annual Dividend: $3.28 per share
Dividend Yield: 2.83%
Merck combines a meaningful dividend yield with an exceptionally high shareholders yield, driven by substantial buybacks. The KEYTRUDA oncology franchise provides a dominant near-term revenue engine, while a deep pipeline supports longer-term income sustainability.
Medtronic (MDT)
Sector: Healthcare
Exchange: NYSE
Medtronic is a global medical device company headquartered in Dublin, Ireland. Its four business segments cover cardiovascular, neuroscience, medical surgical, and diabetes products. It is rated Robust for capital management.
Annual Dividend: $2.13 per share
Dividend Yield: 2.34%
Medtronic has raised its dividend for over 45 consecutive years and trades at a significant discount to estimated fair value. High switching costs in surgical and cardiac devices support predictable recurring revenue, which underpins the dividend commitment.
Ares Capital (ARCC)
Sector: Financial Services
Exchange: NASDAQ
Ares Capital is a Business Development Company (BDC) that provides lending and investment to middle-market businesses. It is one of the largest BDCs in the United States.
Annual Dividend: $1.92 per share
Dividend Yield: 10.25%
A 10.25% yield is the standout feature for income investors. BDCs are structured to distribute the majority of their taxable income as dividends, making ARCC a high-yield vehicle by design rather than by distress. Investors should be aware that BDC dividends can fluctuate with credit cycle conditions and interest rate movements.
Recommended Stock Research
Seeking Alpha is an independent investment research platform offering stock analysis, proprietary data tools, and Quant Ratings to help investors make more informed decisions.
Disclaimer: The information in this article is for educational purposes only and should not be considered financial or investment advice. All figures including AUM, expense ratios, dividend yields, and performance data were accurate at the time of writing in March 2026 and are subject to change with market conditions.
